Converge BIO Ltd.
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Medical device or technology
Converge Bio is transforming drug development with a unified generative AI platform built by experts in ML, bioinformatics, and molecular biology. Our platform enables de novo antibody design, gene expression optimization for improved protein yield, and RNA analysis for patient stratification and target discovery. Trained on DNA, RNA, protein, and SMILES, our models integrate deeply with scientific workflows while preserving data ownership. Unlike black-box or fragmented tools, Converge Bio delivers scalable, explainable, and customizable solutions that accelerate discovery, lower costs, and empower scientists across pharma, biotech, CROs, and CDMOs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}